Clinical trial Recruiting at 1 site Observational Ages 18 and up

How different types of low back pain affect function and quality of life in people with ankylosing spondylitis.

Official title: The Impact of Low Back Pain Phenotypes on Pain Intensity, Functional Status, and Quality of Life in Patients With Ankylosing Spondylitis

Run by Konya Beyhekim Training and Research Hospital · NCT07510789 · Data updated 2026-11-12

This single-visit project will see if different types of low back pain in adults with ankylosing spondylitis relate to pain severity, daily function, and quality of life.

More Low Back Pain trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorKonya Beyhekim Training and Research Hospital
Government
Locations1 site (Konya, Selçuklu)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 1, 2025
Study endsDecember 1, 2026
Registry record updatedApril 3, 2026
Trial IDNCT07510789 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with a diagnosis of ankylosing spondylitis and chronic low back pain lasting at least three months, who can communicate and attend a single clinic visit, are ideal candidates.

Probably not a fit

Patients younger than 18, those with major psychiatric illness, communication barriers, other non-ankylosing-spondylitis causes of back pain, or who require active treatment interventions are unlikely to receive direct benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, hospital-based study will enroll 200 adults with ankylosing spondylitis and chronic low back pain of at least three months, recruited consecutively from the Physical Therapy and Rehabilitation outpatient clinics at Konya Beyhekim Training and Research Hospital. Each participant will complete a standardized, single-session evaluation including questionnaires for pain intensity (VAS), pain catastrophizing (PCS), functional status (RMDQ), disease activity and function (BASDAI, BASFI), and quality of life (ASQoL). Sociodemographic and clinical data will be collected by structured interview, and pain mechanisms will be classified into three categories using validated tools. The analysis will examine how pain phenotypes and their cognitive-emotional components relate to functional status and quality of life.

Why it matters

Potential benefit: If successful, the results could help clinicians tailor pain management by identifying pain types linked to worse function and quality of life in ankylosing spondylitis.

How similar studies have gone: Questionnaire-based studies have previously linked pain characteristics to function in inflammatory back pain, but comprehensive phenotyping that includes cognitive-emotional features in ankylosing spondylitis is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Being over 18 years of age Voluntary participation in the study Having been diagnosed with ankylosing spondylitis

Exclusion Criteria:

* Those under 18 years of age

  * Those with major psychiatric illnesses
  * Those with communication problems
  * Other causes of back pain

Where it's running

  • Konya Beyhekim Eğitim Araştırma Hastanesi
    Konya, Selçuklu, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.